Recurrent Pterygia
Conditions
Keywords
Amniotic membrane, Conjunctival autograft, Recurrent pterygia, compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia
Brief summary
The purpose of this study is to compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia.
Detailed description
Patients with recurrent pterygia without symblepharon were randomly assigned to undertake pterygium excision followed by amniotic membrane associated with a small conjunctival autograft (2x3mm) or conjunctival autograft (approximately 5x8mm) alone. The patients were examined after 1, 7, 30, 90, 180 and 360 days after the surgery. Recurrence was considered as a fibrovascular ingrowth of 1.5 mm or more beyond the limbus with conjunctival drag.
Interventions
PROCEDUREConjunctival autograft versus conjunctival autograft treatment for recurrent pterygia
Amniotic membrane Conjunctival autograft Conjunctival autograft Recurrent pterygia
Sponsors
Federal University of São Paulo
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
15 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
* Recurrent pterygium
Exclusion criteria
* Less than 15 year of age * Symblepharon * Glaucoma, * Ocular Allergy * Ocular surface disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amniotic membrane treatment for recurrent pterygia | one year |
Outcome results
None listed